23/02/2017 |
NeuroVive Pharmaceutical AB |
MAGNUS HANSSON |
Chief Medical Officer |
|
Acquisition |
NeuroVive Pharmaceutical AB |
|
SE0002575340 |
23/02/2017 |
10,000 |
Quantity |
5.65 |
SEK |
|
Notification
|
29/11/2016 |
NeuroVive Pharmaceutical AB |
MATS ESKIL ELMÉR |
Forskningschef |
|
Acquisition |
NeuroVive Pharmaceutical AB |
|
SE0002575340 |
25/11/2016 |
6,000 |
Quantity |
3.35 |
SEK |
|
Notification
|
29/11/2016 |
NeuroVive Pharmaceutical AB |
MATS ESKIL ELMÉR |
Forskningschef |
|
Acquisition |
NeuroVive Pharmaceutical AB |
|
SE0002575340 |
25/11/2016 |
25,000 |
Quantity |
3.45 |
SEK |
|
Notification
|
29/11/2016 |
NeuroVive Pharmaceutical AB |
MATS ESKIL ELMÉR |
Forskningschef |
|
Acquisition |
NeuroVive Pharmaceutical AB |
|
SE0002575340 |
28/11/2016 |
4,000 |
Quantity |
3.40 |
SEK |
|
Notification
|